STOCK TITAN

PureTech Announces Participation in Two Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) will participate in fireside chats at two key investor conferences: Piper Sandler 33rd Annual Virtual Healthcare Conference on November 22, 2021, and Evercore ISI 4th Annual HealthCONx Conference on December 2, 2021.

Presenters include senior management members like George Farmer, Ph.D., and Daphne Zohar. Webcasts will be accessible via their investor relations page, reflecting their commitment to transparency and investor engagement.

Positive
  • None.
Negative
  • None.

Company to participate in fireside chats at Piper Sandler Healthcare Conference and Evercore ISI HealthCONx Conference

BOSTON--(BUSINESS WIRE)-- PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, today announced that members of the management team will participate in fireside chats at the following upcoming investor conferences. Webcasts of the presentations will be available at https://investors.puretechhealth.com/events-presentations.

Members of PureTech’s management team will participate in fireside chats at the Piper Sandler 33rd Annual Virtual Healthcare Conference and Evercore ISI 4th Annual HealthCONx Conference on Monday, November 22, and Thursday, December 2, respectively. (Photo: Business Wire)

Members of PureTech’s management team will participate in fireside chats at the Piper Sandler 33rd Annual Virtual Healthcare Conference and Evercore ISI 4th Annual HealthCONx Conference on Monday, November 22, and Thursday, December 2, respectively. (Photo: Business Wire)

Piper Sandler 33rd Annual Virtual Healthcare Conference
Presenters: George Farmer, Ph.D., Chief Financial Officer; Michael Chen, Ph.D., Head of Innovation
Date: Fireside chat available as of 10:00 AM EST on Monday, November 22, 2021

Evercore ISI 4th Annual HealthCONx Conference
Presenters: Daphne Zohar, Founder and CEO; Michael Chen, Ph.D., Head of Innovation
Date: Thursday, December 2, 2021
Time: 11:45 AM EST

About PureTech Health
PureTech is a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders, among others. The Company has created a broad and deep pipeline through the expertise of its experienced research and development team and its extensive network of scientists, clinicians and industry leaders. This pipeline, which is being advanced both internally and through PureTech's Founded Entities, is comprised of 25 therapeutics and therapeutic candidates, including two that have received both U.S. FDA clearance and European marketing authorization, as of the date of PureTech's most recently filed Half Year Report and corresponding Form 6-K. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points based on the Company's unique insights into the biology of the brain, immune and gut, or BIG, systems and the interface between those systems, referred to as the BIG Axis.

For more information, visit www.puretechhealth.com or connect with us on Twitter @puretechh.

Cautionary Note Regarding Forward-Looking Statements
This press release contains statements that are or may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact, including those related to our participation at upcoming investor conferences, should be considered forward-looking statements. The forward-looking statements are based on current expectations and are subject to known and unknown risks, uncertainties and other important factors that could cause actual results, performance and achievements to differ materially from current expectations, including, but not limited to, those risks, uncertainties and other important factors described under the caption “Risk Factors” in our Annual Report on Form 20-F for the year ended December 31, 2020 filed with the SEC and in our other regulatory filings. These forward-looking statements are based on assumptions regarding the present and future business strategies of the Company and the environment in which it will operate in the future. Each forward-looking statement speaks only as at the date of this press release. Except as required by law and regulatory requirements, we disclaim any obligation to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.

Investors

Allison Mead Talbot

+1 617 651 3156

amt@puretechhealth.com

U.S. media

Nichole Sarkis

+1 774 278 8273

nichole@tenbridgecommunications.com

Source: PureTech Health plc

FAQ

When is PureTech Health participating in the Piper Sandler Healthcare Conference?

PureTech Health will participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference on November 22, 2021.

What time will the fireside chat at the Piper Sandler Conference start?

The fireside chat at the Piper Sandler Conference will be available starting at 10:00 AM EST.

When is the Evercore ISI HealthCONx Conference?

The Evercore ISI 4th Annual HealthCONx Conference will take place on December 2, 2021.

Who will represent PureTech Health at the Evercore ISI HealthCONx Conference?

Daphne Zohar, Founder and CEO, along with Michael Chen, Ph.D., Head of Innovation, will represent PureTech Health.

Where can I watch the webcasts of PureTech Health's presentations?

The webcasts of PureTech Health's presentations will be available on their investor relations page at https://investors.puretechhealth.com/events-presentations.

PureTech Health plc American Depositary Shares

NASDAQ:PRTC

PRTC Rankings

PRTC Latest News

PRTC Stock Data

479.08M
23.94M
0.13%
0.04%
Biotechnology
Healthcare
Link
United States of America
Boston